View Article

Abstract

A virus called the Lyssavirus, which is a member of the Rhabdoviridae family, causes rabies, an infectious disease that damages the brain. It is regarded as a semi-zoonotic acute illness since infected animals usually pass away after exhibiting symptoms. Infected animals' saliva contains the virus, which is mostly spread by animal bites or contaminated saliva from all warm-blooded (homoeothermic) species. Though bats are also a major reservoir in the Americas, dogs are thought to be the most prevalent source of rabies transmission globally. Rabies can incubate for as little as four days or as long as six months, depending on the circumstances. The virus damages the nervous system after entering the body and making its way to the brain. After that, it moves to the salivary glands, where it can be bitten by humans or other animals. Clinical signs of rabies can mimic those of other neurological diseases such botulism, tetanus, and polio. As a result, laboratory validation is crucial, including diagnostic techniques such the mouse inoculation test, direct fluorescent antibody detection, and polymerase chain reaction (PCR). In this essay, the transmission, pathophysiology, treatment, prevention, and control of rabies are reviewed. Proactive preventative measures are essential to stop the spread of this lethal illness because of its high death rate.

Keywords

Lyssavirus, Zoonotic disease, Rhabdoviridae family, Polymerase chain reaction

Introduction

All warm-blooded animals, including humans, are susceptible to rabies, a virus that attacks the central nervous system [1], [2]. Once clinical signs start to show up, this zoonotic disease almost often results in lethal encephalitis in humans and other mammals [3].  Severe neurological symptoms precede paralysis and death as a result of the illness [4].  Rabies is still a fatal but preventable viral illness since there is no effective treatment once symptoms appear [5]. While wild animals serve as the primary hosts in developed regions, dogs are the predominant reservoirs of infection in the majority of underdeveloped countries [6]. Except for a small number of European nations, a number of Caribbean islands, Australia, New Zealand, and Japan, the disease is widespread worldwide.  The vast and mostly uncontrollable reservoir of sylvatic rabies found in wild animals is making the disease a larger hazard to both humans and domestic animals in many parts of the world [1]. Rabies is an acute viral infection of the central nervous system caused by a Lyssavirus belonging to the Rhabdoviridae family [4], [7]. Derived from the Greek word for "rod," "Rhabdo" describes the virus's characteristic rod- or bullet-shaped structure [1]. Rabies can infect any creature, including humans, cats, dogs, wild animals, and livestock.  In animals, the illness typically progresses through three stages: prodromal, excitation (furious), and paralysis (dumb). Human transmission occurs most commonly by bites, scratches, or licks to broken skin or mucous membranes contaminated with infectious saliva [8].  Rabies is still a serious global public health concern, mainly in Africa, Asia, and Latin America, where it is estimated to cause 35,000 deaths annually [6]. The World Health Organisation (WHO) claims that rabies is a neglected tropical disease that mostly strikes impoverished and healthcare-poor countries [12]. According to current estimates, rabies kills approximately 55,000 people annually [7], and there is evidence that the illness is reemerging in a number of places [9]. The most important human transmission vectors are still domestic dogs [13]. However, with prompt medical attention, rabies can be avoided.  The virus can be neutralised before it enters the nervous system by post-exposure prophylaxis (PEP), which consists of administering the rabies vaccine, using immunoglobulins, and providing prompt wound care [7], [14]. The risk of rabies transmission can be considerably decreased by raising public awareness and teaching communities about dog behaviour, how to treat bite victims, and preventative measures [7], [9].  Thus, this review's main goal is to provide current knowledge about rabies prevention and control.

Reference

  1. N. Moges, “Epidemiology, prevention and control methods of rabies in domestic animals: review article,” European Journal of Biological Sciences, vol. 7, no. 2, pp. 85–90, 2015.
  2. O. G. Richard, et al., “A review on human deaths associated with rabies in Nigeria,” Journal of Vaccines & Vaccination, 2015.
  3. T. P. Black and C. E. Rupprecht, “Rhabdoviruses,” in Principles and Practice of Infectious Diseases, G. L. Mandell, et al., Eds., Philadelphia: Elsevier Churchill Livingstone, pp. 2047–2056, 2004.
  4. E. Abera, A. Assefa, S. Belete, and N. Mekonen, “Review on rabies, with emphasis on disease control and eradication measures,” International Journal of Basic and Applied Virology, vol. 4, no. 2, pp. 60–70, 2015.
  5. C. Blackmore, “Rabies prevention and control in Florida,” Division of Disease Control and Health Protection, p. 122, 2014.
  6. C. E. Rupprecht, et al., “Can rabies be eradicated?” Developments in Biologicals, vol. 131, pp. 95–121, 2007.
  7. M. Nilsson, “Effect of a rabies education program on rabies awareness, attitudes towards dogs and animal welfare among children in Lilongwe, Malawi,” Epsilon Examensarbete, p. 26, 2014.
  8. A. C. Jackson, “Why does the prognosis remain so poor in human rabies?” Expert Review of Anti-Infective Therapy, vol. 8, pp. 623–625, 2010.
  9. S. J. Depani, et al., “Evidence of rise in rabies cases in southern Malawi – better preventative measures are urgently required,” Malawi Medical Journal, vol. 24, no. 3, pp. 61–64, 2012.
  10. World Health Organization, “FAQs: Frequently asked questions on rabies,” New Delhi, India, 2013.
  11. American Public Health Association (APHA), “Rabies,” in D. Heymann, Ed., Control of Communicable Diseases Manual, Washington, DC: APHA, pp. 498–508, 2008.
  12. World Health Organization, “Rabies,” 2013. [Online]. Available: http://www.who.int/mediacentre/factsheets/fs099/en/index.html
  13. S. Cleaveland, et al., “Estimating human rabies mortality in the United Republic of Tanzania from dog bite injuries,” Bulletin of the World Health Organization, vol. 80, pp. 304–310, 2002.
  14. N. Permpalung, S. Wongrakpanich, S. Korpaisarn, P. Tanratana, and J. Angsanakul, “Trend of human rabies prophylaxis in developing countries: toward optimal rabies immunization,” Vaccine, vol. 31, pp. 4079–4083, 2013.
  15. M. Warrell, “Rabies encephalitis and its prophylaxis,” Practical Neurology, vol. 1, no. 1, pp. 14–29, 2001.
  16. Center for Food Security and Public Health (CFSPH), Rabies and Rabies-Related Lyssaviruses, Iowa State University, Institute for International Cooperation in Animal Biologics, 2012.
  17. Kahin, The Merck Veterinary Manual, 9th ed., Whitehouse Station, N.J., USA: Merck & Co., Inc., pp. 1067–1071, 2005.
  18. World Organisation for Animal Health (OIE), Manual of Diagnostic Tests and Vaccines for Terrestrial Animals: Rabies, 2008.
  19. L. Dacheux, O. Delmas, and H. Bourhy, “Human rabies encephalitis: prevention and treatment — progress since Pasteur’s discovery,” Biologicals, vol. 40, pp. 61–66, 2012.
  20. A. Eyob, W. Beruktayet, N. Ayalew, and D. Yetayew, “Assessment of the Knowledge, Attitude and Practices of Rabies in Arada Sub City, Addis Ababa, Ethiopia,” International Journal of Basic & Applied Virology, vol. 4, no. 2, pp. 41–52, 2015.
  21. N. Permpalung, S. Wongrakpanich, S. Korpaisarn, P. Tanratana, and J. Angsanakul, “Trend of human rabies prophylaxis in developing countries toward optimal rabies immunization,” Vaccine, vol. 31, pp. 4079–4083, 2013.
  22. A. Belotto, C. Leanes, M. Schneider, H. Tamayo, and E. Correa, “Overview of rabies in the Americas,” Virus Research, vol. 111, p. 512, 2005.
  23. P. Kumar, S. Ganguly, R. Wakchaure, P. Par, K. Qadri, T. Mahajan, N. Dalai, and S. Shekhar, “Rabies, its zoonotic threat and strategies for adoption towards public health welfare: A review,” International Journal of Pharmaceutical & Biomedical Research, vol. 2, no. 6, pp. 26–29, 2015.
  24. M. Potratz, L. M. Zaeck, C. Weigel, A. Klein, C. M. Freuling, T. Müller, and S. Finke, “Neuroglia infection by rabies virus after anterograde virus spread in peripheral neurons,” [Journal Name Missing], 2020.
  25. A. Mahadevan, M. S. Suja, R. S. Mani, and S. K. Shankar, “Perspectives in diagnosis and treatment of rabies viral encephalitis: insights from pathogenesis,” Neurotherapeutics, vol. 13, no. 1, pp. 477–492, 2016.
  26. S. Burgos-Cáceres, “Canine rabies: a looming threat to public health,” Animals (Basel), vol. 1, no. 4, pp. 326–342, 2011.
  27. K. Chacko, R. T. Parakadavathu, M. Al-Maslamani, A. P. Nair, A. P. Chekura, and I. Madhavan, “Diagnostic difficulties in human rabies: a case report and review of the literature,” Qatar Medical Journal, vol. 2016, no. 2, p. 15, 2017.
  28. I. H. Farihah, N. R. A. D. Juliardi, A. B. A. Audia, C. Nabila, and P. Anggrayani, “Neuropathogenesis of human rabies,” International Journal of Health Sciences, vol. 1, no. 4, pp. 375–386, 2022.
  29. E. M. Cárdenas-Canales, C. M. Gigante, L. Greenberg, A. Velasco-Villa, J. A. Ellison, P. S. Satheshkumar, L. G. Medina-Magües, R. Griesser, E. Falendysz, I. Amezcua, J. E. Osorio, and T. E. Rocke, “Clinical presentation and serologic response during a rabies epizootic in captive common vampire bats (Desmodus rotundus),” Tropical Medicine and Infectious Disease, vol. 5, no. 1, p. 34, 2020.
  30. S. A. Jamalkandi, S. H. Mozhgani, H. G. Pourbadie, M. Mirzaie, F. Noorbakhsh, B. Vaziri, A. Gholami, N. Ansari-Pour, and M. Jafari, “Systems biomedicine of rabies delineates the affected signaling pathways,” Frontiers in Microbiology, vol. 7, p. 1688, 2016.
  31. G. Crozet, J. Rivière, L. Canini, F. Cliquet, E. Robardet, and B. Dufour, [Title missing], 2020.
  32. S. Abdulmajid and A. S. Hassan, “Analysis of time delayed rabies model in human and dog populations with controls,” African Matematics, vol. 32, no. 5–6, pp. 1067–1085, 2021.
  33. L. Feige, I. Sáenz-de-Santa-María, B. Regnault, R. Lavenir, A. Lepelletier, A. Ha?acu, R. Rajerison, S. Diop, C. Nareth, J. M. Reynes, P. Buchy, H. Bourhy, and L. Dacheux, “Transcriptome profile during rabies virus infection: identification of human CXCL16 as a potential new viral target,” Frontiers in Cellular and Infection Microbiology, vol. 11, p. 761074, 2021.
  34. H. Zhang, J. Huang, Y. Song, X. Liu, M. Qian, P. Huang, Y. Li, L. Zhao, and H. Wang, [Title missing], 2022.
  35. S. Kim, F. Larrous, H. Varet, R. Legendre, L. Feige, G. Dumas, R. Matsas, G. Kouroupi, R. Grailhe, and H. Bourhy, [Title missing], 2021.
  36. M. J. Warrell and D. A. Warrell, “Rabies: the clinical features, management and prevention of the classic zoonosis,” Clinical Medicine (London), vol. 15, no. 1, pp. 78–81, 2015.
  37. B. Chernet and A. Nejash, “Review of rabies preventions and control,” International Journal of Life Sciences, vol. 4, no. 2, pp. 293–301, 2016.
  38. A. C. Banyard, D. L. Horton, C. Freuling, T. Müller, and A. R. Fooks, “Control and prevention of canine rabies: the need for building laboratory-based surveillance capacity,” Antiviral Research, vol. 98, no. 3, pp. 357–364, 2013.
  39. World Health Organization, “Expert consultation on rabies, 2nd report,” WHO Technical Report Series, no. 982, 2013.
  40. D. K. Yang, E. K. Shin, Y. I. Oh, K. W. Lee, C. S. Lee, S. Y. Kim, J. A. Lee, and J. Y. Song, “Comparison of four diagnostic methods for detecting rabies viruses circulating in Korea,” Journal of Veterinary Science, vol. 13, no. 1, pp. 43–48, 2012.
  41. C. A. Smallman-Raynor, P. Haggett, and M. Matthew, World Atlas of Epidemic Diseases, London: Arnold, pp. 51, 2004.
  42. M. Mustafa, E. M. Ellzam, A. M. Sharifa, M. S. Rahman, M. M. Sien, and M. K. Nang, “Rabies a zoonotic disease, transmission, prevention and treatment,” Journal of Dental and Medical Sciences, vol. 14, no. 10, pp. 82–87, 2015.
  43. C. A. Consales and V. L. Bolzan, “Rabies review: immunopathology, clinical aspects and treatment,” Journal of Venomous Animals and Toxins including Tropical Diseases, vol. 13, no. 1, pp. 5–38, 2007.
  44. E. Abera, A. Assefa, S. Belete, and N. Mekonen, “Review on rabies with emphasis on disease control and eradication measures,” International Journal of Basic and Applied Virology, vol. 4, no. 2, pp. 60–70, 2015.
  45. M. Z. Yousaf, M. Qasim, S. Zia, U. A. Ashfaq, and S. Khan, “Rabies molecular virology, diagnosis, prevention and treatment,” Virology Journal, vol. 9, no. 1, p. 1, 2012.
  46. A. C. Jackson, M. J. Warrell, and C. E. Rupprecht, “Management of rabies in humans,” Clinical Infectious Diseases, vol. 36, pp. 60–63, 2003.
  47. D. J. Dean, G. M. Baer, and W. R. Thompson, “Studies on the local treatment of rabies-infected wounds,” Bulletin of the World Health Organization, vol. 28, no. 4, pp. 477, 1963.
  48. P. Gautret, J. Blanton, L. Dacheux, F. Ribadeau-Dumas, P. Brouqui, P. Parola, D. H. Esposito, and H. Bourhy, “Rabies in non-human primates and potential for transmission to humans: a literature review and examination of selected French national data,” PLoS Neglected Tropical Diseases, vol. 8, no. 5, p. e2863, 2014.
  49. G. L. Geison, “Pasteur’s work on rabies: reexamining the ethical issues,” Hastings Center Report, vol. 8, no. 2, pp. 26–33, 1978.
  50. S. Ly, P. Buchy, and N. Y. Heng, “Rabies situation in Cambodia,” PLoS Neglected Tropical Diseases, vol. 3, no. 9, p. e511, 2009.
  51. J. F. Reece and S. K. Chawla, “Control of rabies in Jaipur, India by the sterilization,” [Journal name missing], 2006.
  52. K. Tojinbara, K. Sugiura, A. Yamada, I. Kakitani, and N. C. Kwan, “Estimating the probability distribution of the incubation period for rabies using data from the 1948–1954 rabies epidemic in Tokyo,” Preventive Veterinary Medicine, vol. 123, pp. 102–105, 2016.
  53. S. Cleaveland, M. Kaare, D. Knobel, and M. K. Laurenson, “Canine vaccination—providing broader benefits for disease control,” Veterinary Microbiology, vol. 117, no. 1, pp. 43–50, 2006.
  54. World Society for the Protection of Animals, Methods for the Control of Dog Populations: A Guide for Policymakers. London, U.K.: World Society for the Protection of Animals, 2007.
  55. Centers for Disease Control and Prevention (CDC), “Compendium of animal rabies prevention and control, National Association of State Public Veterinarians,” Morbidity and Mortality Weekly Report, pp. 1–7, 2001.
  56. O. M. Radostits, C. C. Gay, K. W. Hincheliff, and P. D. Constable, Veterinary Medicine: A Textbook of the Diseases of Cattle, Sheep, Pigs, Goats and Horses, 10th ed., London: Saunders Elsevier, pp. 1384–1387, 2007.
  57. K. Murray, K. Holmes, and C. Hanlon, “Rabies in vaccinated dogs and cats in the United States,” Journal of the American Veterinary Medical Association, vol. 235, pp. 691–695, 2009.
  58. D. Asefa, P. Mahendra, M. Hailu, H. Abraham, and D. Ritwik, “Rabies: a major fatal viral disease of humans and animals in Ethiopia,” Journal of Natural History, vol. 11, no. 2, pp. 19–25, 2015.

Photo
Dipali Pagar
Corresponding author

K.B.H.S.S. Institute of Pharmacy Malegaon, Nashik

Photo
Roshani More
Co-author

K.B.H.S.S. Institute of Pharmacy Malegaon, Nashik

Photo
Bhavisha Chaudhari
Co-author

K.B.H.S.S. Institute of Pharmacy Malegaon, Nashik

Dipali Pagar*, Roshani More, Bhavisha Chaudhari, Review on: Strategies for Preventing and Controlling Rabies Disease, Int. J. Sci. R. Tech., 2025, 2 (11), 157-165. https://doi.org/10.5281/zenodo.17553948

More related articles
Assessment of Physicochemical Properties and Polyc...
Adedosu Haleema Omolola, Ogunmoroti, E.A., Ayoola, P. B, Adedosu,...
Disparities in Access to Essential Medicines in In...
Arnab Roy, Alok Kumar , Ankit Kumar Srivastava , Faijan Ansari ,...
Sustainable Urban Landscape Design - Concept, Purp...
Purvi Dabhi, Isha Pandya, Bharat Maitreya, ...
Formulation and Evalution of Diclofenac Gel...
Bhaiyyasaheb Kokare, Dr. Priti Shinde, ...
Microspheres as A Multiparticulate Drug Delivery Systems: A Comprehensive Review...
Prajval Birajdar, Dr. Amol Borade, Ashwini Karnakoti, Kartik Shinde, Mangesh Dagale, Vishal Bodke, ...
Related Articles
Immunopharmacology of Trained Immunity in Infectious and Non-Infectious Diseases...
Pratiksha Vyavahare, Kranti Akhare, Dr. N. P. Sawadadkar, Dr. N. R. Kayande, ...
A Review on Role of Colophony in Different Formulation...
Rushikesh Sanap, Sarukh Vikram, Pund Sonali, Bhad Manoj, Araj Ishwar, ...
Evaluation of Chronic Low-Level Exposure to Cypermethrin and Dichlorvos on Oxida...
Akinyele Abdulmuiz Akindamola, Afolabi Olusegun Kayode, Adedeji Adebayo Lawrence, Okesanjo Abdulazee...
The Science Behind Lavender in Insomnia Natural Sleep Aid: A Comprehensive Revie...
Lomash sahu , Shivaji Patel, Vivek Patel, Rajesh Kumar Nema, Suchita Wamankar, ...
Assessment of Physicochemical Properties and Polycyclic Aromatic Hydrocarbons (P...
Adedosu Haleema Omolola, Ogunmoroti, E.A., Ayoola, P. B, Adedosu, T. A., ...
More related articles
Assessment of Physicochemical Properties and Polycyclic Aromatic Hydrocarbons (P...
Adedosu Haleema Omolola, Ogunmoroti, E.A., Ayoola, P. B, Adedosu, T. A., ...
Disparities in Access to Essential Medicines in India: A Systematic Review of Av...
Arnab Roy, Alok Kumar , Ankit Kumar Srivastava , Faijan Ansari , Kishor Kumar , Madhu Vishwakarma ...
Assessment of Physicochemical Properties and Polycyclic Aromatic Hydrocarbons (P...
Adedosu Haleema Omolola, Ogunmoroti, E.A., Ayoola, P. B, Adedosu, T. A., ...
Disparities in Access to Essential Medicines in India: A Systematic Review of Av...
Arnab Roy, Alok Kumar , Ankit Kumar Srivastava , Faijan Ansari , Kishor Kumar , Madhu Vishwakarma ...